Veterinary Vaccines - Global Market Outlook (2017-2026)

Veterinary Vaccines - Global Market Outlook (2017-2026)

  • Published: August 2018
  • ID: SMRC17517

According to Stratistics MRC, the Global Veterinary Vaccines Market is accounted for $6.44 billion in 2017 and is expected to reach $11.73 billion by 2026 growing at a CAGR of 6.9% from 2017 to 2026. Growing figure of livestock disease, Increasing Adoption of Companion Animals and Rising frequency of Zoonotic diseases are some of the factors that are fuelling the market growth. On the other side, high costs are hampering the market growth. However, Awareness in emerging country regarding animal health provides ample opportunity to the market. Veterinary vaccines are important for animal health, animal welfare, food production, and public health. They are a cost-effective method to prevent animal disease among animals as well as humans.

On the basis of technology, DNA Vaccines uses a gene from a virus or bacteria to stimulate the immune system. They can be made in a short time span it is easier to make large amounts of a gene than make proteins or grow up bacteria or viruses. Speed is important when making a vaccine to strains of bacteria or virus that are constantly mutating and changing and does not need to be stored at low temperatures making transportation and storage cheaper and easier than conventional vaccines.

North America by geography among all other regions is expected to have highest market share throughout the forecasting period due to the awareness for prevention of animal-to-human transmission diseases and lower investment in research and development in the animal vaccine on compared to human vaccine area may propel the Veterinary Vaccines market.

Some of the key players of veterinary vaccines market include Jinyu Bio-Technology, China Animal Husbandry, Tianjin Ringpu, Biogenesis Bago, Idt Biologika, Hipra, Hester, Phibro Animal Health, Vetoquinol, Virbac, Merck Animal Health, Zoetis, Boehringer Ingelheim, Elanco and Ceva.

Types Covered:
• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Companion Animal Vaccines
• Cattle Vaccines
• Aquaculture Vaccines
• Veterinary Viral Vaccines
• Veterinary Bacterial Vaccines
• Veterinary Parasite Vaccines
• Veterinary Vaccines for Infectious Diseases
• Other Animal Vaccines

Technologies Covered:
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Subunit vaccines 
• DNA vaccines        
• Conjugate vaccines  
• Other Vaccines

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary      
        
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis     
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Technology Analysis    
 3.7 Emerging Markets     
 3.8 Futuristic Market Scenario    
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Veterinary Vaccines Market, By Type             
 5.1 Introduction      
 5.2 Porcine Vaccines      
  5.2.1 Porcine Parvovirus    
  5.2.2 Porcine Reproductive Respiratory Syndrome 
  5.2.3 Porcine Circovirus II    
  5.2.4 Swine Influenza    
  5.2.5 Auzeszky’s Disease    
  5.2.6 Swine Pneumonia    
 5.3 Poultry Vaccines      
  5.3.1 Bronchits     
  5.3.2 Avian influenza    
  5.3.3 Newcastle disease           
  5.3.4 Marek's disease            
 5.4 Livestock Vaccines      
  5.4.1 Bovine Vaccines    
   5.4.1.1 Bovine Viral Diarrhea  
   5.4.1.2 Brucellosis   
   5.4.1.3 Foot and mouth disease  
   5.4.1.4 Bovine Clostridial disease  
   5.4.1.5 Infectious Bovine Rhinotracheitis 
  5.4.2 Small Ruminant Vaccines   
 5.5 Companion Animal Vaccines     
  5.5.1 Canine Vaccines    
   5.5.1.1 Distemper   
   5.5.1.2 Kennel cough (Parainfluenza)  
   5.5.1.3 Parvovirus   
   5.5.1.4 Canine herpes   
   5.5.1.5 Lyme Disease   
  5.5.2 Equine Vaccines    
   5.5.2.1 Rhinopneumonitis   
   5.5.2.2 Influenza    
   5.5.2.3 Encephalomyelitis   
   5.5.2.4 Strangles    
   5.5.2.5 Tetanus    
  5.5.3 Feline Vaccines    
   5.5.3.1 Feline calicivirus   
   5.5.3.2 Peritonitis (FIP)   
   5.5.3.3 Feline FIV   
 5.6 Cattle Vaccines     
  5.6.1 BRSV     
  5.6.2 Enzootic Bronchopneu   
  5.6.3 IBR     
  5.6.4 BVD/MD     
 5.7 Aquaculture Vaccines     
 5.8 Veterinary Viral Vaccines    
  5.8.1 Live Viral Vaccines    
  5.8.2 Inactivated Viral Vaccines   
  5.8.3 DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
  5.8.4 Molecularly Defined Subunit Vaccines  
  5.8.5 Genetically Engineered Viral Vaccines  
  5.8.6 Live Viral Vector Vaccines   
  5.8.7 DNA Vaccines    
 5.9 Veterinary Bacterial Vaccines    
  5.9.1 Conventional Live Vaccines   
  5.9.2 Conventional Inactivated Vaccines  
  5.9.3 Gene-Deleted Vaccines   
  5.9.4 Subunit Vaccines    
 5.10 Veterinary Parasite Vaccines    
  5.10.1 Protozoal Vaccines    
  5.10.2 Subunit Protozoal Parasite Vaccines  
  5.10.3 Helminth and Ectoparasite Vaccines  
 5.11 Veterinary Vaccines for Infectious Diseases  
  5.11.1  Allergy Vaccines    
  5.11.2 Cancer Vaccines    
 5.12 Other Animal Vaccines    
        
6 Global Veterinary Vaccines Market, By Technology            
 6.1 Introduction     
 6.2 Live Attenuated Vaccines     
 6.3 Inactivated Vaccines     
 6.4 Toxoid Vaccines      
 6.5 Recombinant Vaccines     
 6.6 Subunit vaccines       
 6.7 DNA vaccines              
 6.8 Conjugate vaccines       
 6.9 Other Vaccines     
        
7 Global Veterinary Vaccines Market, By Geography   
 7.1 Introduction     
 7.2 North America     
  7.2.1 US     
  7.2.2 Canada     
  7.2.3 Mexico     
 7.3 Europe      
  7.3.1 Germany     
  7.3.2 UK     
  7.3.3 Italy     
  7.3.4 France     
  7.3.5 Spain     
  7.3.6 Rest of Europe    
 7.4 Asia Pacific     
  7.4.1 Japan     
  7.4.2 China     
  7.4.3 India     
  7.4.4 Australia     
  7.4.5 New Zealand    
  7.4.6 South Korea    
  7.4.7 Rest of Asia Pacific    
 7.5 South America     
  7.5.1 Argentina    
  7.5.2 Brazil     
  7.5.3 Chile     
  7.5.4 Rest of South America   
 7.6 Middle East & Africa    
  7.6.1 Saudi Arabia    
  7.6.2 UAE     
  7.6.3 Qatar     
  7.6.4 South Africa    
  7.6.5 Rest of Middle East & Africa   
        
8 Key Developments      
 8.1 Acquisitions & Mergers    
 8.2 Agreements, Partnerships, Collaborations and Joint Ventures 
 8.3 Product Launch & Expansions     
 8.4 Other Activities     
        
9 Company Profiling      
 9.1 Bayer Healthcare     
 9.2 Jinyu Bio-Technology    
 9.3 Tianjin Ringpu     
 9.4 Biogenesis Bago     
 9.5 Idt Biologika      
 9.6 Hipra      
 9.7 Hester       
 9.8 Phibro Animal Health    
 9.9 Vetoquinol      
 9.10 Virbac      
 9.11 Merck Animal Health    
 9.12 Zoetis animal healthcare    
 9.13 Boehringer Ingelheim    
 9.14 Elanco      
 9.15 Ceva      
 9.16 China Animal Husbandry     
 9.17 Embrex Inc.     
 9.18 Fort Dodge Animal Health    
 9.19 Imugene Limited     
 9.20 Bioniche Animal Health    


List of Tables       
1 Global Veterinary Vaccines Market Outlook, By Region (2016-2026) ($MN)
2 Global Veterinary Vaccines Market Outlook, By Type (2016-2026) ($MN) 
3 Global Veterinary Vaccines Market Outlook, By Porcine Vaccines (2016-2026) ($MN)
4 Global Veterinary Vaccines Market Outlook, By Porcine Parvovirus (2016-2026) ($MN)
5 Global Veterinary Vaccines Market Outlook, By Porcine Reproductive Respiratory Syndrome (2016-2026) ($MN)
6 Global Veterinary Vaccines Market Outlook, By Porcine Circovirus II (2016-2026) ($MN)
7 Global Veterinary Vaccines Market Outlook, By Swine Influenza (2016-2026) ($MN)
8 Global Veterinary Vaccines Market Outlook, By Auzeszky’s Disease (2016-2026) ($MN)
9 Global Veterinary Vaccines Market Outlook, By Swine Pneumonia (2016-2026) ($MN)
10 Global Veterinary Vaccines Market Outlook, By Poultry Vaccines  (2016-2026) ($MN)
11 Global Veterinary Vaccines Market Outlook, By Bronchits (2016-2026) ($MN)
12 Global Veterinary Vaccines Market Outlook, By Avian influenza (2016-2026) ($MN)
13 Global Veterinary Vaccines Market Outlook, By Newcastle disease (2016-2026) ($MN)
14 Global Veterinary Vaccines Market Outlook, By Marek's disease (2016-2026) ($MN)
15 Global Veterinary Vaccines Market Outlook, By Livestock Vaccines  (2016-2026) ($MN)
16 Global Veterinary Vaccines Market Outlook, By Bovine Vaccines (2016-2026) ($MN)
17 Global Veterinary Vaccines Market Outlook, By Small Ruminant Vaccines (2016-2026) ($MN)
18 Global Veterinary Vaccines Market Outlook, By Companion Animal Vaccines  (2016-2026) ($MN)
19 Global Veterinary Vaccines Market Outlook, By Canine Vaccines (2016-2026) ($MN)
20 Global Veterinary Vaccines Market Outlook, By Equine Vaccines (2016-2026) ($MN)
21 Global Veterinary Vaccines Market Outlook, By Feline Vaccines (2016-2026) ($MN)
22 Global Veterinary Vaccines Market Outlook, By Cattle Vaccines (2016-2026) ($MN)
23 Global Veterinary Vaccines Market Outlook, By BRSV (2016-2026) ($MN) 
24 Global Veterinary Vaccines Market Outlook, By Enzootic Bronchopneu (2016-2026) ($MN)
25 Global Veterinary Vaccines Market Outlook, By IBR (2016-2026) ($MN) 
26 Global Veterinary Vaccines Market Outlook, By BVD/MD (2016-2026) ($MN)
27 Global Veterinary Vaccines Market Outlook, By Aquaculture Vaccines  (2016-2026) ($MN)
28 Global Veterinary Vaccines Market Outlook, By Veterinary Viral Vaccines (2016-2026) ($MN)
29 Global Veterinary Vaccines Market Outlook, By Live Viral Vaccines (2016-2026) ($MN)
30 Global Veterinary Vaccines Market Outlook, By Inactivated Viral Vaccines (2016-2026) ($MN)
31 Global Veterinary Vaccines Market Outlook, By DIVA Vaccines (Differentiating Infected from Vaccinated Animals) (2016-2026) ($MN)
32 Global Veterinary Vaccines Market Outlook, By Molecularly Defined Subunit Vaccines (2016-2026) ($MN)
33 Global Veterinary Vaccines Market Outlook, By Genetically Engineered Viral Vaccines (2016-2026) ($MN)
34 Global Veterinary Vaccines Market Outlook, By Live Viral Vector Vaccines (2016-2026) ($MN)
35 Global Veterinary Vaccines Market Outlook, By DNA Vaccines (2016-2026) ($MN)
36 Global Veterinary Vaccines Market Outlook, By Veterinary Bacterial Vaccines (2016-2026) ($MN)
37 Global Veterinary Vaccines Market Outlook, By Conventional Live Vaccines (2016-2026) ($MN)
38 Global Veterinary Vaccines Market Outlook, By Conventional Inactivated Vaccines (2016-2026) ($MN)
39 Global Veterinary Vaccines Market Outlook, By Gene-Deleted Vaccines (2016-2026) ($MN)
40 Global Veterinary Vaccines Market Outlook, By Subunit Vaccines (2016-2026) ($MN)
41 Global Veterinary Vaccines Market Outlook, By Veterinary Parasite Vaccines (2016-2026) ($MN)
42 Global Veterinary Vaccines Market Outlook, By Protozoal Vaccines (2016-2026) ($MN)
43 Global Veterinary Vaccines Market Outlook, By Subunit Protozoal Parasite Vaccines (2016-2026) ($MN)
44 Global Veterinary Vaccines Market Outlook, By Helminth and Ectoparasite Vaccines (2016-2026) ($MN)
45 Global Veterinary Vaccines Market Outlook, By Veterinary Vaccines for Infectious Diseases (2016-2026) ($MN)
46 Global Veterinary Vaccines Market Outlook, By Allergy Vaccines (2016-2026) ($MN)
47 Global Veterinary Vaccines Market Outlook, By Cancer Vaccines (2016-2026) ($MN)
48 Global Veterinary Vaccines Market Outlook, By Other Animal Vaccines (2016-2026) ($MN)
49 Global Veterinary Vaccines Market Outlook, By Technology (2016-2026) ($MN)
50 Global Veterinary Vaccines Market Outlook, By Live Attenuated Vaccines  (2016-2026) ($MN)
51 Global Veterinary Vaccines Market Outlook, By Inactivated Vaccines  (2016-2026) ($MN)
52 Global Veterinary Vaccines Market Outlook, By Toxoid Vaccines  (2016-2026) ($MN)
53 Global Veterinary Vaccines Market Outlook, By Recombinant Vaccines  (2016-2026) ($MN)
54 Global Veterinary Vaccines Market Outlook, By Subunit vaccines (2016-2026) ($MN)
55 Global Veterinary Vaccines Market Outlook, By DNA vaccines (2016-2026) ($MN)
56 Global Veterinary Vaccines Market Outlook, By Conjugate vaccines (2016-2026) ($MN)
57 Global Veterinary Vaccines Market Outlook, By Other Vaccines (2016-2026) ($MN)
        
NOTE:   North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in above manner.

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials